Clinical Biomaterials Researchers examine materials intended for medical applications that directly interact with human tissues. Their work involves evaluating biocompatibility, mechanical durability, and the long-term stability of both synthetic and natural biomaterials under physiological conditions. They focus on how these materials affect cellular responses and tissue repair processes, aiming to minimize adverse effects such as inflammation, toxicity, or rejection. Their research supports the design and improvement of medical devices and implants that enhance patient safety and treatment outcomes.
Collaborating with clinicians, engineers, and regulatory experts, Clinical Biomaterials Researchers perform extensive testing to meet clinical and safety standards. They investigate novel biomaterials that encourage tissue integration, prevent infection, and improve the mechanical and functional performance of medical products. Their contributions influence a broad range of clinical tools, including vascular grafts, orthopedic implants, and drug delivery systems. Their work ensures higher standards in medical material safety and effectiveness. By advancing the understanding of material–tissue interactions, they promote better healing and recovery. Their efforts are crucial to the development of innovative clinical therapies and devices. They continually explore new materials to enhance biocompatibility and reduce side effects. Their research supports the design of longer-lasting and more reliable implants. Through interdisciplinary collaboration, they accelerate the translation of biomaterial innovations into clinical practice.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy